RFP ANNOUNCEMENT: IN VITRO AND ANIMAL MODELS FOR EMERGING INFECTIOUS DISEASES
AND BIODEFENSE - NIH-NIAID-DMID-04-40
RELEASE DATE: December 16, 2003
NOTICE: NOT-AI-04-013
National Institute of Allergy and Infectious Diseases (NIAID)
(http://www.niaid.nih.gov/)
RECEIPT DATE: March 1, 2004
DESCRIPTION
The National Institute of Allergy and Infectious Diseases is soliciting
offers from organizations with the expertise to undertake targeted research
essential to the development of therapeutics, diagnostics, and preventive
measures for emerging infectious diseases, including bioterrorism agents.
The emphasis is to cover agents found at the NIAID Category A, B & C Priority
Pathogens website. This list is a subset of the NIAID List of Emerging and
Re-emerging Diseases 2003.
The statement of work for this effort is divided into six Parts: A) In vitro
screening, B) Clinical isolate panels, C) Small animal models, D) Non-human
primate models, E) Safety/toxicology and immunogenicity testing of vaccines,
and F) Safety/toxicology and pharmacology testing of therapeutics. These
Parts will provide a ready capacity in a number of needed areas and will be
utilized as products become available for testing. Test articles that are
found to have activity in Part A may progress through development using
contractors from other parts.
It is anticipated that multiple contract awards will be made for each part of
this Indefinite-Delivery, Indefinite-Quantity (IDIQ) solicitation. After the
basic contract awards are made, task orders will be competed in accordance
with FAR Part 16.505 under Parts A, B, C, D, E or F based on the specific
requirements of the task order. The RFP contains one sample task order for
each of these six parts for evaluation purposes. In response to this RFP,
potential Offerors may submit proposals for one or more of the six Parts
described above. For Parts A and B, Offerors should propose as many
organisms or groups of organisms as possible. Within Parts C and D, Offerors
may submit proposals for one or more of the models using the same
organisms/disease or models for more than one organism/disease. Offerors for
Parts E and F should propose comprehensive services to cover all aspects of
the Statement of Work. All Offerors that receive a contract award are
eligible for the guaranteed minimum(s). Offerors that receive awards for
more than one Part will be eligible for the guaranteed minimum for each Part
awarded. Offerors that make the Contractor pool and can provide multiple
organisms/models within a Part will be eligible for a single minimum for that
Part. The following scale will determine the guaranteed minimum dollar
awards for each Part:
Part A $75,000
Part B $75,000
Part C $100,000
Part D $150,000
Part E $100,000
Part F $100,000
NIAID anticipates the award of these contracts beginning approximately
September 30, 2004. RFP NIH-NIAID-DMID-04-40 will be available
electronically on or about December 16, 2003 and may be accessed at
http://www.niaid.nih.gov/contract/rfps.htm or http://www.fedbizopps.gov/.
Only electronic copies of the solicitation will be available. All
information required for the submission of an offer will be contained in the
solicitation. Responses to this RFP will be due approximately March 1, 2004.
The NAICS Code applicable to this requirement is 541710. The small business
size standard is 500 employees. Subcontracting is encouraged. Any
responsible Offeror may submit a proposal that will be considered by the
Government, however, this notice does not commit the Government to the award
of a contract. No collect calls will be accepted.
CONTRACTING OFFICE ADDRESS
Department of Health and Human Services
National Institutes of Health
National Institute of Allergy and Infectious Diseases
Division of Extramural Activities
Contract Management Program
6700-B Rockledge Drive
Room 2230, MSC 7612
Bethesda, MD 20892-7605
POINT OF CONTACT
Paquetta Myrick-Hancock, Contract Specialist, Phone 301-451-3692,
Fax 301-480-5253, Email [email protected]
Paul McFarlane, Senior Contracting Officer, Phone 301-496-0349,
Fax 301-402-0972, Email [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
Department of Health and Human Services (HHS) |
|
||||
|
NIH... Turning Discovery Into Health® |
||||||